These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 1385345
21. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin. Rodriguez M, Galas MC, Lignon MF, Mendre C, Laur J, Aumelas A, Martinez J. J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546 [Abstract] [Full Text] [Related]
22. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties. Charpentier B, Durieux C, Menant I, Roques BP. J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407 [Abstract] [Full Text] [Related]
23. 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin. Fulcrand P, Rodriguez M, Galas MC, Lignon MF, Laur J, Aumelas A, Martinez J. Int J Pept Protein Res; 1988 Nov; 32(5):384-95. PubMed ID: 2463231 [Abstract] [Full Text] [Related]
24. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists. Gonzalez-Muniz R, Bergeron F, Marseigne I, Durieux C, Roques BP. J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834 [Abstract] [Full Text] [Related]
25. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D. Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [Abstract] [Full Text] [Related]
26. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists. Nagain C, Galas MC, Lignon MF, Rodriguez M, Martinez J, Rozé C. Pancreas; 1991 May; 6(3):275-81. PubMed ID: 1713671 [Abstract] [Full Text] [Related]
27. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179. Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D. Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190 [Abstract] [Full Text] [Related]
28. Biological effects of newly synthesized cholecystokinin analogs. Verspohl EJ, LaMura M. Horm Res; 2000 Mar 01; 53(4):177-84. PubMed ID: 11044801 [Abstract] [Full Text] [Related]
29. New evidence for a membrane-bound pathway in hormone receptor binding. Moroder L, Romano R, Guba W, Mierke DF, Kessler H, Delporte C, Winand J, Christophe J. Biochemistry; 1993 Dec 14; 32(49):13551-9. PubMed ID: 7504952 [Abstract] [Full Text] [Related]
30. Occupation of low-affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells. Vinayek R, Patto RJ, Menozzi D, Gregory J, Mrozinski JE, Jensen RT, Gardner JD. Biochim Biophys Acta; 1993 Mar 10; 1176(1-2):183-91. PubMed ID: 7680902 [Abstract] [Full Text] [Related]
31. Models for the A- and B-receptor-bound conformations of CCK-8. Nikiforovich GV, Hruby VJ. Biochem Biophys Res Commun; 1993 Jul 15; 194(1):9-16. PubMed ID: 8333874 [Abstract] [Full Text] [Related]
32. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives. Weng JH, Blommaert AG, Moizo L, Bado A, Ducos B, Böhme A, Garbay C, Roques BP. Bioorg Med Chem; 1996 Apr 15; 4(4):563-73. PubMed ID: 8735845 [Abstract] [Full Text] [Related]
33. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors. Menozzi D, Stark HA, Martinez J, Jensen RT, Gardner JD. Peptides; 1989 Apr 15; 10(2):337-41. PubMed ID: 2474153 [Abstract] [Full Text] [Related]
34. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region. Rolland M, Rodriguez M, Lignon MF, Galas MC, Laur J, Aumelas A, Martinez J. Int J Pept Protein Res; 1991 Aug 15; 38(2):181-92. PubMed ID: 1723720 [Abstract] [Full Text] [Related]
35. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists. Low CM, Black JW, Broughton HB, Buck IM, Davies JM, Dunstone DJ, Hull RA, Kalindjian SB, McDonald IM, Pether MJ, Shankley NP, Steel KI. J Med Chem; 2000 Sep 21; 43(19):3505-17. PubMed ID: 11000005 [Abstract] [Full Text] [Related]
36. Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists. Shiosaki K, Lin CW, Kopecka H, Tufano MD, Bianchi BR, Miller TR, Witte DG, Nadzan AM. J Med Chem; 1991 Sep 21; 34(9):2837-42. PubMed ID: 1716682 [Abstract] [Full Text] [Related]
37. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD, Knight M, Sutliff VE, Jensen RT. Am J Physiol; 1985 Jan 21; 248(1 Pt 1):G98-102. PubMed ID: 2578257 [Abstract] [Full Text] [Related]
38. Evidence for cholecystokinin receptor subtype in endocrine pancreas. Verspohl EJ, Hafner B, He X, Knittel JJ. Peptides; 1994 Jan 21; 15(8):1353-60. PubMed ID: 7535422 [Abstract] [Full Text] [Related]
39. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas. Otsuki M, Okabayashi Y, Ohki A, Oka T, Fujii M, Nakamura T, Sugiura N, Yanaihara N, Baba S. Am J Physiol; 1986 Apr 21; 250(4 Pt 1):G405-11. PubMed ID: 2421584 [Abstract] [Full Text] [Related]
40. Enzyme-resistant CCK analogs with high affinities for central receptors. Charpentier B, Durieux C, Pelaprat D, Dor A, Reibaud M, Blanchard JC, Roques BP. Peptides; 1988 Apr 21; 9(4):835-41. PubMed ID: 3226959 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]